|
||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||
Product Information: Most mammalian species have multiple IFN-Alpha subtypes. Although the reasons for these multiple subtypes are not fully known, there are clear cell type and temporal differences in their expression. A recent study established a nomenclature for the murine IFN-Alpha subtypes (van Pesch et al. 2004) and determined relative activities of the subtypes with protein quantification by phosphorimaging of metabolically-labeled protein. In this study, Mu IFN-Alpha4 was deemed to have average antiviral activity when compared with the potency of the other subtypes. Mu IFN-Alpha4 was initially cloned by Zwarthoff et al. [(1985) Nuc. Acids Res. 13(3) 791], and has been extensively studied. It is apparently expressed early in viral infection in a protein synthesis independent manner, and its expression is induced by phosphorylation of IRF-3. It may be that Mouse IFN-Alpha4, like IFN-β, has a priming function on cells, enabling the expression of other Mouse IFN-Alpha subtypes [Reviewed by Mesplède et al. (2003) Autoimmunity 36(8):447 and Asselin-Paturel & Trinchieri (2005) J. Exp. Med. 202(4):461]. Thus, this interferon is among the first observed after viral infection. Intriguingly, while this interferon is expressed in a large variety of cell types, one report suggests that the expression level in dendritic cells is low to non-existent [Barchet et al. (2002) J. Exp. Med. 195(4):507] Summary: Mouse IFN-Alpha4 is a widely expressed Mouse IFN-Alpha which may play a major role in preparing cells to express high levels of other Mouse IFN-Alpha subtypes upon viral challenge. |
||||||||||||||||||||||||||